A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
Stopped Poor recruitment
Conditions
Interventions
- DRUG: AEZS-108
- DRUG: AEZS-108 at MTD
Sponsor
AEterna Zentaris
Collaborators
- [object Object]
- [object Object]
- [object Object]